<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1021/acschemneuro.5b00324</dc:identifier><dc:language>eng</dc:language><dc:creator>Horrocks, M.H.</dc:creator><dc:creator>Lee, S.F.</dc:creator><dc:creator>Gandhi, S.</dc:creator><dc:creator>Magdalinou, N.K.</dc:creator><dc:creator>Chen, S.W.</dc:creator><dc:creator>Devine, M.J.</dc:creator><dc:creator>Tosatto, L.</dc:creator><dc:creator>Kjaergaard, M.</dc:creator><dc:creator>Beckwith, J.S.</dc:creator><dc:creator>Zetterberg, H.</dc:creator><dc:creator>Iljina, M.</dc:creator><dc:creator>Cremades, N.</dc:creator><dc:creator>Dobson, C.M.</dc:creator><dc:creator>Wood, N.W.</dc:creator><dc:creator>Klenerman, D.</dc:creator><dc:title>Single-molecule imaging of individual amyloid protein aggregates in human biofluids</dc:title><dc:identifier>ART-2016-107780</dc:identifier><dc:description>The misfolding and aggregation of proteins into amyloid fibrils characterizes many neurodegenerative disorders such as Parkinson’s and Alzheimer’s diseases. We report here a method, termed SAVE (single aggregate visualization by enhancement) imaging, for the ultrasensitive detection of individual amyloid fibrils and oligomers using single-molecule fluorescence microscopy. We demonstrate that this method is able to detect the presence of amyloid aggregates of a-synuclein, tau, and amyloid-ß. In addition, we show that aggregates can also be identified in human cerebrospinal fluid (CSF). Significantly, we see a twofold increase in the average aggregate concentration in CSF from Parkinson’s disease patients compared to age-matched controls. Taken together, we conclude that this method provides an opportunity to characterize the structural nature of amyloid aggregates in a key biofluid, and therefore has the potential to study disease progression in both animal models and humans to enhance our understanding of neurodegenerative disorders.</dc:description><dc:date>2016</dc:date><dc:source>http://zaguan.unizar.es/record/75425</dc:source><dc:doi>10.1021/acschemneuro.5b00324</dc:doi><dc:identifier>http://zaguan.unizar.es/record/75425</dc:identifier><dc:identifier>oai:zaguan.unizar.es:75425</dc:identifier><dc:identifier.citation>ACS CHEMICAL NEUROSCIENCE 7, 3 (2016), 399-406</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>